Medical Education

Health

First new drug in years reduces recurrence in high risk HR+ early breast cancer

Lugano, Switzerland, 20 September 2020 – Adding abemaciclib to hormonal therapy reduces the risk of cancer recurrence by 25% in…

Read More »
Health

New first-line treatment option for metastatic kidney cancer

Lugano, Switzerland, 19 September 2020 – The results of the phase 3 CheckMate 9ER trial have provided a new first-line…

Read More »
Back to top button
Close